Hayes's purchases are not happening in isolation. On-chain data shows that accumulation-focused wallets — addresses with no history of selling — purchased over 1.11 million ETH in the same seven-day period, the highest accumulation rate recorded in all of 2026 . At the same time, exchanges registered a net inflow of 178,900 ETH, which some analysts interpret as mixed sentiment: short-term sellers coexist with long-term whales pulling coins off exchanges via OTC and cold storage
. This tug-of-war is a classic feature of accumulation phases, where price weakness shakes out weaker hands while larger players build positions.
Hayes used Flowdesk and Cumberland precisely to avoid slippage and visible order-book impact . When a whale buys 1,500 to 3,000 ETH on a public exchange order book, the purchase can push the price up against itself, making the acquisition more expensive. OTC execution lets him accumulate size without signaling intent to the broader market
. This is a deliberate institutional tactic.
Hayes has stated he expects ETH to reach $10,000 to $20,000 before the end of the current market cycle, calling it a core holding in his portfolio . He has described Ethereum as the public blockchain for traditional finance (TradFi) that wants to come on-chain
.
His Bitcoin outlook is more complicated. As of early 2026, Hayes set a year-end BTC target of $500,000 . But at Consensus Miami in May 2026, he cut that target by 75% to $125,000, citing AI-related macro risks
. The $500K target is his pre-May stance, not his current one. On-chain monitors have also noted he reportedly holds a $38.9 million long Bitcoin position and has been selling some altcoins to allocate fresh capital to ETH
.
The combination of Hayes's personal buying and the broader accumulation record paints a clear picture:
Arthur Hayes is deploying capital at a time when Ethereum is on track for its second-worst first-half performance since 2022, trading near $1,700. His actions align with his stated view that ETH can 10x or more from current levels, and the broader on-chain data shows the widest institutional and whale accumulation of 2026 happening alongside that same weakness. This is consistent with the classic "buy when there's blood in the streets" playbook — executed via OTC to avoid tipping off the market.